Rheumatic diseases are a group of conditions that affect the joints, muscles, and bones. These diseases can cause pain, swelling, and stiffness in the affected areas. They can also cause fatigue, fever, and loss of appetite. Common rheumatic diseases include rheumatoid arthritis, osteoarthritis, gout, lupus, and fibromyalgia. Treatment for these diseases typically involves medications, physical therapy, and lifestyle changes.
The rheumatic disease market is composed of companies that develop and market treatments for these conditions. These companies include pharmaceutical companies that develop medications, medical device companies that develop products to help manage symptoms, and biotechnology companies that develop treatments using gene therapy and other advanced technologies. Additionally, there are companies that provide services such as physical therapy and lifestyle counseling.
Companies in the rheumatic disease market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more
